TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS financial statements, including revenue, expenses, profit, and loss
The total revenue of 0LER for the last quarter is 4.16 B USD, and it's 8.61% higher compared to the previous quarter. The net income of Q2 24 is -845.00 M USD.